Related Experiment Video
Updated: Apr 3, 2026

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
Chemically modified tetracyclines: The novel host modulating agents
Devulapalli Narasimha Swamy1, Sahitya Sanivarapu1, Srinivas Moogla1
1Department of Periodontics, SIBAR Institute of Dental Sciences, Guntur, Andhra Pradesh, India.
Chemically modified tetracyclines (CMTs) show promise as host modulation agents for periodontitis. These drugs inhibit destructive enzymes and reduce inflammation, offering a new therapeutic approach for periodontal disease.
Area of Science:
- Periodontology
- Pharmacology
Background:
- Periodontitis involves pathogens and destructive host responses.
- Understanding pathogenesis drives new treatment concepts like host response modulation.
- Various drugs are explored as host modulation agents (HMA).
Purpose of the Study:
- To evaluate chemically modified tetracyclines (CMTs) as potential host modulating agents for periodontitis.
- To highlight the anticollagenolytic properties of CMTs.
- To explore CMTs' ability to modulate pro- and anti-inflammatory mediators.
Main Methods:
- Review of existing literature on host modulation agents in periodontitis.
- Focus on the mechanism of action of chemically modified tetracyclines (CMTs).
- Analysis of CMTs' effects on collagenolytic activity and inflammatory mediators.
Main Results:
- Chemically modified tetracyclines (CMTs) possess anticollagenolytic properties.
- CMTs are designed as potent inhibitors of pro-inflammatory mediators.
- CMTs can increase the levels of anti-inflammatory mediators.
Conclusions:
- Chemically modified tetracyclines (CMTs) represent a promising class of host modulating agents for periodontitis.
- Their ability to target collagenolytic activity and inflammatory pathways offers therapeutic potential.
- Further research into CMTs could lead to novel treatments for periodontal disease.
More Related Videos
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
08:14Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Inhibitors of Bacterial Protein Synthesis
Anthelminthic Agents
Modified-Release Drug Delivery Systems: Site-Targeted
Biological Methods for Microbial Control
Modified-Release Drug Delivery Systems: Stimuli-Activated